Gainers
- Intelligent Living Application Group Inc. (NASDAQ: ILAG) surged 77.7% to $9.35.
- Gravitas Education Holdings, Inc. (NASDAQ: GEHI) shares jumped 66% to $24.90.
- Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 40% to $3.4028. Avenue Therapeutics recently priced a roughly 3.6 million unit offering at $3.30 per unit.
- Agrify Corporation (NASDAQ: AGFY) surged 38.9% to $1.31.
- IMARA Inc. (NASDAQ: IMRA) shares gained 35.4% to $3.4950 after the company, along with Enliven Therapeutics, announced a merger agreement to combine the two companies in an all-stock transaction.
- Sunshine Biopharma, Inc. (NASDAQ: SBFM) jumped 35% to $0.88.
- ShiftPixy, Inc. (NASDAQ: PIXY) surged 29% to $14.19.
- Brilliant Earth Group, Inc. (NASDAQ: BRLT) gained 29.7% to $7.54.
- Nutanix, Inc. (NASDAQ: NTNX) jumped 24.4% to $26.30 following a WSJ report indicating the company is exploring a sale after receiving takeover interest.
- Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares rose 22.8% to $0.2837 after declining around 7% on Thursday. CONNEXA, last month, announced a $5.0 million private placement.
- Rubicon Technologies, Inc. (NYSE: RBT) gained 20.5% to $1.70. Rubicon Technologies named Phil Rodoni as CEO.
- Ecoark Holdings, Inc. (NASDAQ: ZEST) surged 18.6% to $0.8069.
- Reata Pharmaceuticals, Inc. (NASDAQ: RETA) surged 18.3% to $29.63. Reata Pharmaceuticals said FDA does not plan to hold advisory committee meeting to discuss the NDA for Omaveloxolone for Friedreich's Ataxia.
- Applied Therapeutics, Inc. (NASDAQ: APLT) gained 17% to $0.6690. Applied Therapeutics CEO Shoshana Shendelman reported purchase of 73,256 shares at an average price of $0.56 per share in Form 4 filing on Thursday.
- Laser Photonics Corporation (NASDAQ: LASE) rose 14.7% to $4.7399 after the company announced it is implementing an aggressive hiring campaign due to a sizeable increase in leads and inquiries.
- NLS Pharmaceutics AG (NASDAQ: NLSP) gained 14.3% to $0.56.
- Castellum, Inc. (NYSE: CTM) jumped 14.2% to $1.3701. Castellum announced pricing of $3 million public offering of 1.5 million shares at a price of $2.00 per share.
- Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) rose 14.1% to $3.6750.
- Revelation Biosciences, Inc. (NASDAQ: REVB) gained 12.6% to $0.2673. Revelation Biosciences recently announced an exclusive worldwide license agreement with Vanderbilt University to develop and commercialize phosphorylated hexaacyl disaccharide, for treating or preventing infections.
- Zymeworks Inc. (NASDAQ: ZYME) jumped 10.2% to $5.39.
- TH International Limited (NASDAQ: THCH) rose 10.9% to $4.57.
- Allarity Therapeutics, Inc. (NASDAQ: ALLR) rose 9.5% to $0.85. Allarity Therapeutics recently regains compliance with NASDAQ Listing Requirements.
- WiSA Technologies, Inc. (NASDAQ: WISA) jumped 7% to $0.6095.
- Wells Fargo (NYSE:WFC) & Company (NYSE: WFC) climbed 4.4% to $44.24 after the company reported Q3 financial results.
- JPMorgan Chase & Co. (NYSE: NYSE:JPM) rose 3.4% to $113.07 after the company reported better-than-expected Q3 EPS results.
- Citigroup Inc. (NYSE: NYSE:C) gained 2.8% to $44.15 after the company reported better-than-expected Q3 EPS and sales results.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers
- Novo Integrated Sciences, Inc. (NASDAQ: NVOS) fell 54.4% to $0.3423 after the company announced pricing of $2 million public offering of 4 million units at $0.50 per unit.
- Minerva Surgical, Inc. (NASDAQ: UTRS) dropped 29.5% to $0.4195.
- Nuwellis, Inc. (NASDAQ: NUWE) fell 24.3% to $0.2522 after dropping 10% on Thursday. Nuwellis recently announced results of the AVOID-HF clinical study analysis at the 2022 HFSA meeting, showing a "statistically superior clinical benefit of Aquadex therapy in reducing heart failure events and mortality."
- Schmitt Industries, Inc. (NASDAQ: SMIT) dropped 20.1% to $1.59. Shares of several companies in the broader technology sector trade lower amid a rise in treasury yields, which has pressured growth stocks
- First Republic Bank (NYSE: FRC) shares tumbled 14.4% to $115.35 after the company reported mixed Q3 results.
- Applied DNA Sciences, Inc. (NASDAQ: APDN) dropped 14% to $2.4250.
- AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) dipped 13.7% to $0.1749.
- ACM Research, Inc. (NASDAQ: ACMR) fell 13.3% to $8.22. Shares of several companies in the broader technology sector traded lower amid a rise in treasury yields, which has pressured growth stocks.
- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) dropped 13.2% to $0.1822. Salarius Pharmaceuticals announced a 1-for-25 reverse stock split beginning with the opening of trading on October 17.
- Peloton (NASDAQ:PTON) Interactive, Inc. (NASDAQ: PTON) fell 11.3% to $7.72.
- X Financial (NYSE: XYF) dropped 10.2% to $1.76. X Financial recently upsized share repurchase program from $15 million to $20 million.
- Arrival (NASDAQ: ARVL) declined 10.2% to $0.6620.
- Cyxtera Technologies, Inc. (NASDAQ: CYXT) dropped 9.6% to $3.1050.
- The Mosaic Company (NYSE: NYSE:MOS) fell 9.2% to $47.24.
- Nutex Health Inc. (NASDAQ: NUTX) fell 8% to $0.8788 after jumping 72% on Thursday. Nutex recently provided a corporate update.
- Fathom Holdings Inc. (NASDAQ: FTHM) fell 6.6% to $4.14.
- Morgan Stanley (NYSE: NYSE:MS) dropped 4% to $76.16 after the company reported Q3 EPS and sales results down from last year.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.